Annual Report 2006

Stakeholder group

Engagement activities

Outcome

3) In June 2006 IDF launched the campaign ‘Unite for Diabetes’, which Novo Nordisk supports together with patient organisations, medical associations and the industry. On 20 December, the General Assembly of the United Nations adopted, by consensus, a Resolution on diabetes. Novo Nordisk is committed to continuing to play an active role in the campaign in order to ensure that action is taken and that each of the UN Member States establishes national policies on the treatment, prevention and care of diabetes.

Customers (healthcare
providers)

National Changing Diabetes Programme
(NDCP)

NCDP helps build national healthcare capacity and develop national disease strategies, based on partnership with many stakeholders. Activities include educating nurses and doctors in diabetes care.

Employees

1) Employee volunteering - TakeAction!

1) Through the Novo Nordisk School Challenge, employees reached children in 2006 with messages about healthy lifestyle.

2) Employee health - NovoSund

2) In 2006 Employees participated in NovoSund activities such as smoking cessation programmes, five-kilometre company relay run and a stress pilot survey.

Policy-makers

1) Novo Nordisk’s Government Affairs office
in Washington DC

1) The development of a national effort to promote Medicare screening for diabetes and pre-diabetes.

2) Changing Diabetes Bus

2) The Changing Diabetes Bus has reached policy-makers, the public, media healthcare professionals, and people with diabetes at every stop of its journey, and by the end of 2006 more than 28,000 people have visited the Changing Diabetes Bus. See more details here.

Local communities

1) Employee volunteering - TakeAction!

1) Employees from Novo Nordisk Israel educated volunteers and healthcare providers in the Jewish orthodox and Arab communities on how to overcome patient barriers to proper diabetes treatment.

2) Neighbour meetings

2) Novo Nordisk regularly hosts neighbour meetings in connection with new production facilities, expansions etc.

Investors

1) Capital Markets Day (CMD)

1) At the yearly CMD meeting Novo Nordisk's financial performance and sustainable business practices are presented to key investors. The company hereby helps edcating investors about the importance of Corporate Responsibility to long-term business success.

2) SRI questionnaires

2) The dialogue with analysts, investors and rating agencies enables Novo Nordisk to better understand how non-financial performance is seen as either risk or opportunity indicators from an investor perspective.

Suppliers

Responsible Sourcing Programme

Novo Nordisk expects that suppliers adhere to the company's standards for managing environmental impacts and respecting human and labour rights. Selected suppliers are assessed before contracting into a business relationship. All existing suppliers are regularly evaluated on their performance. See supplier toolbox here.  

NGOs

1) WWF’s Climate Savers programme

1) Through the Climate Savers agreement, Novo Nordisk is committed to reducing total CO2 emissions in 2014 to 10% below the level in 2004. See more details here.

2) Collaboration regarding animal welfare

2) Novo Nordisk collaborates with animal welfare and animal rights organisations, among those the Danish Animal Welfare Society. In partnership we have identified ways to improve the welfare of animals at Novo Nordisk, with special attention to housing.

Peers/business partners

SustainAbility’s Engaging Stakeholders programme

Engagement meetings with peers enables Novo Nordisk to discuss dilemmas, challenges and opportunities with peers facing similar sustainability-related issues.

Academia

1) Novo Nordisk regularly gives lectures at CBS, and participates in research into topics related to brand and reputation management, CSR and business cases.

Novo Nordisk employs several PhD students and collaborates on thesis and papers.

2) Lise Kingo (executive vice president
and chief of staffs) is external professor in Sustainability and Innovation at the Vrije Universiteit, Netherlands.

2) Lise Kingo was in June appointed external professor in Sustainability and Innovation at the Faculty of Medicine of the Vrije Universiteit in Amsterdam. Several times a year, she will return to Amsterdam to give lectures – an extension of Novo Nordisk’s collaboration with the university in several other areas. Download Lise Kingo’s inauguration speech here.